BAC
Bank of America Corporation
BAC has the edge over GBLI overall, supported by stronger fundamentals and stronger modeled upside.
GBLI
Global Indemnity Group, LLC
GBLI offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
GBLI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
GBLI's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like GBLI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over GBLI in the historical PE scenario, which offers more potential upside but is not a forecast.
GBLI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $22.15 | — |
| Cheap | 12x | $25.56 | +15% |
| Fair | 15x | $31.97 | +44% |
| Expensive | 47x | $100 | +352% |
Historical ranges are pointers, not guarantees.
GBLI's PE is in its cheap range at 10x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
GBLI Forward outlook
There aren't enough analyst estimates for GBLI to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over GBLI on earnings, with more consistent year-over-year improvement.
GBLI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.14 | +11% |
| Q2 2026 | $2.39 | +21% |
| Q1 2026 | $2.34 | +17% |
| Q4 2025 | $1.75 | -44% |
| Q3 2025 | $1.92 | -34% |
| Q2 2025 | $1.98 | -22% |
| Q1 2025 | $2.00 | -19% |
| Q4 2024 | $3.12 | +70% |
GBLI's earnings per share have fallen from their peak: $2.14 over the past year, against $4.88 in late 2019.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over GBLI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over GBLI on profitability, with a higher operating margin.
GBLI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.9M | -1.1% |
| Q2 2026 | $116.1M | +5.1% |
| Q1 2026 | $109.2M | +0.5% |
| Q4 2025 | $116.7M | +7.6% |
| Q3 2025 | $114.2M | +2.2% |
| Q2 2025 | $110.5M | +1.7% |
| Q1 2025 | $108.7M | -3.2% |
| Q4 2024 | $108.4M | -0.7% |
GBLI's revenue fell from its 2022 peak and has held roughly level since: $113M last quarter, down 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -3.8 points |
| Q2 2026 | 12% | +0.5 points |
| Q1 2026 | 5% | +9.7 points |
| Q4 2025 | 7.9% | -3.3 points |
| Q3 2025 | 14% | -0.1 points |
| Q2 2025 | 12% | +0.2 points |
| Q1 2025 | -4.7% | -17 points |
| Q4 2024 | 11% | +3.2 points |
GBLI's operating margin was 10% last quarter, down 3.8 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over GBLI on cash generation, producing positive trailing cash flow while its opponent burns cash.
GBLI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.1M | +112% |
| Q2 2026 | -$15.8M | -326% |
| Q1 2026 | -$17.9M | -845% |
| Q4 2025 | -$6M | +$7.4M |
| Q3 2025 | $5.7M | -63% |
| Q2 2025 | $7M | -51% |
| Q1 2025 | $2.4M | -89% |
| Q4 2024 | -$13.4M | -319% |
GBLI's free cash flow was −$28M over the past year, against $2M the year before. Free cash flow isn't a meaningful measure for financial services companies like GBLI.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over GBLI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
GBLI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +32.8K shares |
| 1 year | +0.7% | +101K shares |
| 3 years | +4.7% | +644K shares |
| 5 years | +0.1% | +13.2K shares |
| Available history | +0.9% | +124K shares |
GBLI has 14M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $529,000 |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $6.1M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
GBLI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.7x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
GBLI has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
GBLI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 27.2 | Neutral |
GBLI's weekly RSI is 32 (neutral) and its Stochastic is 27 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
GBLI PE vs Financial Services Sector
| Metric | GBLI | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 21% below |
| PE % | 7 | 63 | 56 pts below |
GBLI has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over GBLI on trend strength, trading above more of its moving averages.
GBLI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.8 | 6.9% below |
| 20 week MA | $26.1 | 15% below |
| 50 week MA | $27.1 | 18% below |
| 100 week MA | $29.4 | 25% below |
| 200 week MA | $30.6 | 28% below |
GBLI is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over GBLI on returns for 2026, with the stronger performance.
GBLI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.0 | $27.9 | -4% |
| 2021 | $27.9 | $25.1 | -10% |
| 2022 | $25.1 | $23.6 | -5.8% |
| 2023 | $23.6 | $32.2 | +37% |
| 2024 | $32.2 | $35.7 | +11% |
| 2025 | $35.7 | $27.9 | -22% |
| 2026 YTD | $27.9 | $22.2 | -21% |
GBLI has finished lower in four of the last six years. It's down 21% so far in 2026.